Articles

Robust Monitoring of Pharmaceutical Manufacturing Operations Based on Combined NIR and Raman Spectroscopy

Blending processes are one of the key manufacturing steps in pharmaceutical preparation, as optimal blend homogeneity is crucial to ensure correct dosage.
Post Date: 09/01/2010
Author: Christine Voura, Andreas E. Posch, Gudrun Hörl, Daniel M. Koller, Simon D. ...

Funny Pharm: You Write the Caption & Win: August-September 2010

Introducing "Funny Pharm," sponsored by Paratherm Corp., featuring drawings by award-winning cartoonist Jerry King. Submit your caption and win.
Post Date: 08/26/2010
Author:

From Go-Karts to Formula 1: Distinguishing True Digital Signatures

Digital signatures have grown in sophistication and import, becoming a staple of serious and compliant drug manufacturers, explains SAFE-Biopharma's Mollie Shields-Uehling.
Post Date: 08/23/2010
Author: Paul Thomas, Senior Editor

How New Packaging Technologies are Helping in the Struggle Against Counterfeit Drugs

This article discusses counterfeit drugs, current regulations and the latest packaging technologies.
Post Date: 08/23/2010
Author: Richard Burhouse, Business Development Manager, Payne Security

Keeping Your Cool: Tips for Maintaining Your Cooling Towers

Here's how to protect process cooling systems from costly summertime fatigue.
Post Date: 08/19/2010
Author: Ed Sullivan

The Evolving LIMS, and What It Means for the Pharmaceutical Lab

A look into the laboratory's integrated, and on-demand, future with Thermo Fisher expert Kim Shah.
Post Date: 08/19/2010
Author: Paul Thomas, Senior Editor

PharmaView: What's In Your Wastewater? It's Time to Find Out

We have little grasp of the downstream impact of API's being discharged from our facilities.
Post Date: 08/16/2010
Author: Paul Thomas, Senior Editor

Pharma Water Everywhere, but Little Consistent Guidance

Guidelines for pharma grade water have varied and often been a moving target. Pfizer's Cameron Sipe explains the importance of ISPE's new guidelines.
Post Date: 08/16/2010
Author:

Drugs in Wastewater: A Call for More Research, More Responsibility

Manufacturers must practice a heightened sense of "Pharmecovigilance" regarding drug compounds leaving their facilities as waste, says a leading expert.
Post Date: 08/16/2010
Author: Paul Thomas, Senior Editor

Using RMM for Environmental Monitoring

Rapid microbiological methods can also be used for air and surface monitoring, with modest regulatory resistance.
Post Date: 08/16/2010
Author: Dawn McIver, President, MicroWorks, Inc.

Connecting Data to the Patient: Paul McKenzie on J&J Pharma R&D's Lab-to-Patient Program

Paul McKenzie, global head of pharmaceutical development and manufacturing sciences for J&J pharmaceutical research and development, shares goals for J&J's pharmaceutical R&D, and the "Lab to Patient" program.
Post Date: 08/11/2010
Author:

Time and Cost Identified as Key Roadblocks to PAT and QbD; Experts Disagree

Results suggest that concerns about time and cost are dampening pharma's enthusiasm for PAT and QbD: Experts examined these issues in a July webcast.
Post Date: 08/11/2010
Author: Agnes Shanley, Editor in Chief

Funny Pharm: You Write the Caption & Win: August 2010

Introducing "Funny Pharm," sponsored by Paratherm Corp., featuring drawings by award-winning cartoonist Jerry King. Submit your caption and win.
Post Date: 08/05/2010
Author:

Digital Insights: “Presenteeism” From Afar: Is Your Vacation A Blackberry-Free Zone?

Is your family vacation a blackberry-free zone?
Post Date: 08/03/2010
Author: Michele Vaccarello Wagner, Senior Digital Editor

Therapeutic Dose: Throwing out the Bathwater, the Baby, the Tub . . .
Big manufacturers have forgotten why they grew big in the first place, to the severe detriment of their PAT and QbD programs, says Contributing Editor Emil Ciurczak.
Post Date: 08/03/2010
Author: Emil Ciurczak, Contributing Editor

Contract Manufacturing: Orchestrating the Dance

Lean Six Sigma, expertise in microbiology, and shop-floor experience all contribute to running a flexible, efficient contract facility, says DPT’s new director of sterile ops.
Post Date: 08/03/2010
Author: Paul Thomas, Senior Editor

How Lean is Pharma?: A 10-Year Progress Report

So much is to be gained, yet it is hard to tell whether any drug manufacturer has truly made progress over the last decade.
Post Date: 08/03/2010
Author: Robert E. Spector, Principal, Tunnell Consulting

From the Editor: How Good is Your Data (And Can You Find It)?

Forget, for the moment, about process understanding and control. How are you doing on basic document retrieval?
Post Date: 08/02/2010
Author: Agnes Shanley, Editor in Chief

A QbD Implementation Roadmap for the Generics Industry
Following a structured framework with clearly defined metrics at each stage gate will ensure a new level of quality for generics. Pharmatech's Bikash Chatterjee outlines a five-phase approach.
Post Date: 07/30/2010
Author:

Biotech Production: Planning, Scheduling and Throughput Analysis with a Combined Theory of Constraints, Lean and Simulation Approach

A major biotech company's only final stage bio-manufacturing facility in the world was struggling to meet rapidly increasing customer demand. Unanticipated production delays and frequent starvations at critical parts of the operation were causing not only late and missed deliveries, but also the expiration of ...
Post Date: 07/22/2010
Author: